Published in Immunology on December 01, 1999
Severe schistosomiasis in the absence of interleukin-4 (IL-4) is IL-12 independent. Infect Immun (2001) 0.83
The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy. Parasit Vectors (2010) 0.80
Cytokine Pattern of T Lymphocytes in Acute Schistosomiasis mansoni Patients following Treated Praziquantel Therapy. J Parasitol Res (2013) 0.79
Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells. Clin Exp Immunol (2002) 0.78
T regulatory cell responses to immunization with a soluble egg antigen in Schistosoma mansoni-infected mice. Korean J Parasitol (2012) 0.77
Identification of a novel T-cell epitope in soluble egg antigen of Schistosoma japonicum. Infect Immun (2001) 0.75
Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol (1988) 5.80
Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med (1991) 5.04
Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J Immunol (1991) 3.65
Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity (1995) 3.23
Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol (1996) 2.69
An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature (1995) 2.52
A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem (1985) 2.46
Cytotoxic T lymphocytes against a soluble protein. Nature (1987) 2.36
CD8+ T cells can be primed in vitro to produce IL-4. J Immunol (1992) 1.91
Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev (1989) 1.79
Localization of atrial natriuretic peptide mRNA and immunoreactivity in the rat heart and human atrial appendage. Proc Natl Acad Sci U S A (1987) 1.74
Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection. Infect Immun (1986) 1.71
Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology (1989) 1.47
A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J Immunol (1987) 1.39
Adoptive suppression of granuloma formation. J Exp Med (1976) 1.38
Lymphokine regulation of granuloma formation in murine schistosomiasis mansoni. Clin Immunol Immunopathol (1993) 1.38
Characterization of granuloma T lymphocyte function from Schistosoma mansoni-infected mice. J Immunol (1989) 1.25
Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni. Eur J Immunol (1997) 1.21
Evolving T cell responses in murine schistosomiasis. Th2 cells mediate secondary granulomatous hypersensitivity and are regulated by CD8+ T cells in vivo. J Immunol (1993) 1.21
Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunol (1991) 1.15
Cross-regulatory role of interferon-gamma (IFN-gamma), IL-4 and IL-10 in schistosome egg granuloma formation: in vivo regulation of Th activity and inflammation. Clin Exp Immunol (1994) 1.14
Recombinant IL-2 therapy reverses diminished granulomatous responsiveness in anti-L3T4-treated, Schistosoma mansoni-infected mice. J Immunol (1990) 1.12
Immunopathology of granuloma formation and fibrosis in schistosomiasis. Parasitol Today (1986) 1.10
T lymphocytes that contribute to the immunoregulation of granuloma formation in chronic murine schistosomiasis. J Immunol (1981) 1.08
Type 1 CD8+ T cell responses during infection with the helminth Schistosoma mansoni. J Immunol (1996) 1.02
Distinction of mouse CD8+ suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms. J Immunol (1993) 1.00
Cytolytic T lymphocytes recognize alloantigens on schistosomula of Schistosoma mansoni, but fail to induce damage. J Immunol (1979) 0.98
Multiple sites of post-activation CD8+ T cell disposal. Eur J Immunol (1997) 0.97
Protective effect of rSm28GST-specific T cells in schistosomiasis: role of gamma interferon. Infect Immun (1994) 0.95
Induction of cytotoxic T-cell activity by the protective antigen of Schistosoma mansoni Sm28GST or its derived C-terminal lipopeptide. Scand J Immunol (1996) 0.93
In vitro granuloma formation using defined antigenic nidi. Ann N Y Acad Sci (1986) 0.92
Unimpaired down-modulation of the hepatic granulomatous response in CD8 T-cell- and gamma interferon-deficient mice chronically infected with Schistosoma mansoni. Infect Immun (1997) 0.90
Fibroblast stimulation in schistosomiasis. VII. Egg granulomas secrete factors that stimulate collagen and fibronectin synthesis. J Immunol (1987) 0.89
The molecular basis of granuloma formation in schistosomiasis. I. A T cell-derived suppressor effector factor. J Immunol (1988) 0.89
Regulation of granulomatous inflammation in murine schistosomiasis. IV. Antigen-induced suppressor T cells down-regulate proliferation and IL-2 production. J Immunol (1990) 0.87
Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation. Eur J Immunol (1994) 0.85
Induction of hepatic egg granuloma hyporesponsiveness in murine schistosomiasis mansoni by intravenous injection of small doses of soluble egg antigen. APMIS (1997) 0.84
Immunological response of major histocompatibility complex class II-deficient (Abeta(o)) mice infected by the parasite Schistosoma mansoni. Scand J Immunol (1998) 0.80
Generation and characterization of peptide-specific, MHC-restricted cytotoxic T lymphocyte (CTL) and helper T cell lines from unprimed T cells under microculture conditions. J Immunol Methods (1990) 0.77
A new function for platelets: IgE-dependent killing of schistosomes. Nature (1983) 2.11
The receptor for IgE on blood platelets. Eur J Immunol (1986) 1.32
Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol (1998) 1.29
Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites of Toxoplasma gondii. Parasite Immunol (1988) 1.15
Infection of mice lacking interleukin-7 (IL-7) reveals an unexpected role for IL-7 in the development of the parasite Schistosoma mansoni. Infect Immun (1999) 1.08
Protective role of IgE in immunocompromised rat toxoplasmosis. J Immunol (1988) 1.07
Infection of B-cell-deficient mice by the parasite Schistosoma mansoni: demonstration of the participation of B cells in granuloma modulation. Scand J Immunol (1998) 1.05
In vitro and in vivo effects of interleukin 2 on the protozoan parasite leishmania. Eur J Immunol (1989) 1.04
Protection of nude rats against Toxoplasma infection by excreted-secreted antigen-specific helper T cells. Infect Immun (1990) 1.03
Obtention of a human primary humoral response against schistosome protective antigens in severe combined immunodeficiency mice after the transfer of human peripheral blood mononuclear cells. Eur J Immunol (1991) 1.03
New functions for platelets and their pathological implications. Int Arch Allergy Appl Immunol (1985) 1.03
Recombinant tumor necrosis factors mediate platelet cytotoxicity to Schistosoma mansoni larvae. J Immunol (1988) 1.02
Interleukin-10-mediated T cell apoptosis during the T helper type 2 cytokine response in murine Schistosoma mansoni parasite infection. Eur Cytokine Netw (1997) 1.01
Platelet cytotoxicity against parasites. Nouv Rev Fr Hematol (1991) 0.98
Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. J Immunol (1992) 0.98
IgE-dependent killing of Brugia malayi microfilariae by human platelets and its modulation by T cell products. Int Arch Allergy Appl Immunol (1988) 0.97
Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations. J Infect Dis (2000) 0.97
Protective effect of rSm28GST-specific T cells in schistosomiasis: role of gamma interferon. Infect Immun (1994) 0.95
Antigenicity and immunogenicity of P30-derived peptides in experimental models of toxoplasmosis. Mol Immunol (1994) 0.95
Rat IgE directed against schistosomula-released products is cytotoxic for Schistosoma mansoni schistosomula in vitro. Eur J Immunol (1984) 0.95
Induction of platelet cytotoxic functions by lymphokines: role of interferon-gamma. J Immunol (1987) 0.94
Induction of cytotoxic T-cell activity by the protective antigen of Schistosoma mansoni Sm28GST or its derived C-terminal lipopeptide. Scand J Immunol (1996) 0.93
Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus. Blood (1997) 0.92
Characterization and synthesis of a macrophage inhibitory peptide from the second constant domain of human immunoglobulin G. FEBS Lett (1983) 0.91
IFN-gamma-derived lipopeptides: influence of lipid modification on the conformation and the ability to induce MHC class II expression on murine and human cells. J Med Chem (1999) 0.91
Inhibitory effects of cyclosporine on human regulatory T cells in vitro. Transplant Proc (2009) 0.91
Identification of T cell epitopes within a 23-kD antigen (P24) of Toxoplasma gondii. Clin Exp Immunol (1991) 0.91
Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1 antigen. J Immunol (1989) 0.90
Quantitative PCR: validation of the use of a multispecific internal control. Nucleic Acids Res (1994) 0.89
Cellular immune responses of a Senegalese community recently exposed to Schistosoma mansoni: correlations of infection level with age and inflammatory cytokine production by soluble egg antigen-specific cells. Trop Med Int Health (1999) 0.89
Neutral protease activities at different developmental stages of Schistosoma mansoni in mammalian hosts. Comp Biochem Physiol B (1982) 0.89
A suppressive lymphokine of platelet cytotoxic functions. J Immunol (1986) 0.89
Proteolytic cleavage of IgG bound to the Fc receptor of Schistosoma mansoni schistosomula. Parasite Immunol (1981) 0.89
Protection against experimental Schistosoma mansoni schistosomiasis achieved by immunization with schistosomula released products antigens (SRP-A): role of IgE antibodies. Clin Exp Immunol (1986) 0.88
Ocular transfer of retinal glial cells transduced ex vivo with adenovirus expressing viral IL-10 or CTLA4-Ig inhibits experimental autoimmune uveoretinitis. Gene Ther (2003) 0.88
Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene. Clin Exp Immunol (2002) 0.87
Does Epstein-Barr virus infection confer selective advantage to malaria-infected children? Lancet (1993) 0.87
Unrestricted agonist activity on murine and human cells of a lipopeptide derived from IFN-gamma. Biochem Biophys Res Commun (1998) 0.87
Platelets as effectors in immune and hypersensitivity reactions. Int Arch Allergy Appl Immunol (1987) 0.87
[Infection of the athymic rat by Toxoplasma gondii]. C R Acad Sci III (1987) 0.87
Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation. Am J Transplant (2009) 0.87
Productive human immunodeficiency virus-1 infection of megakaryocytic cells is enhanced by tumor necrosis factor-alpha. Blood (1992) 0.86
Analysis of the V beta specificity of superantigen activation with a rapid and sensitive method using RT PCR and an automatic DNA analyser. J Immunol Methods (1994) 0.85
Effect of ubiquitin on platelet functions: possible identity with platelet activity suppressive lymphokine (PASL). Eur J Immunol (1991) 0.85
Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration. Clin Exp Immunol (1986) 0.85
Dermal endothelial cells and keratinocytes produce IL-7 in vivo after human Schistosoma mansoni percutaneous infection. J Immunol (1998) 0.84
Functional properties of a rat monoclonal IgE antibody specific for Schistosoma mansoni. J Immunol (1987) 0.84
A radioimmunoassay for the quantification of human ubiquitin in biological fluids: application to parasitic and allergic diseases. J Immunol Methods (1994) 0.84
Interleukin-7 in the skin of Schistosoma mansoni-infected mice is associated with a decrease in interferon-gamma production and leads to an aggravation of the disease. Immunology (1997) 0.83
Fast evolution of interleukin-2 in mammals and positive selection in ruminants. J Mol Evol (2000) 0.83
Analysis of the immune response elicited by a multiple antigen peptide (MAP) composed of two distinct protective antigens derived from the parasite Schistosoma mansoni. Parasite Immunol (1997) 0.82
Measurement of picogram quantities of rat IgE from in vitro culture supernatants of B lymphocytes in experimental helminth infections. Int Arch Allergy Appl Immunol (1986) 0.82
Induction of a protective immune IgE response in rats by injection of defined antigens of schistosomulum-released products: immunochemical properties of the target antigens. Int Arch Allergy Appl Immunol (1986) 0.82
Detection of human antibodies using "convergent" combinatorial peptide libraries or "mixotopes" designed from a nonvariable antigen: application to the EBV viral capsid antigen p18. J Pept Res (1998) 0.82
Schistosoma mansoni-infected mice show augmented hepatic fibrosis and selective inhibition of liver cytokine production after treatment with anti-NK1.1 antibodies. Immunol Lett (1996) 0.81
Cutaneous interleukin-7 transgenic mice display a propitious environment to Schistosoma mansoni infection. Parasite Immunol (2001) 0.81
Structural diversity of human class II histocompatibility molecules induced by peptide ligands. FEBS Lett (2000) 0.81
IgG subclass-associated differences in anti-schistosomal antibody specificity. Scand J Immunol (1994) 0.81
Evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay using a synthetic convergent peptide library, or mixotope, for diagnosis of primary EBV infection. J Clin Microbiol (1999) 0.81
IgE-dependent killing of Schistosoma mansoni schistosomula by human platelets: modulation by T cell products. Int Arch Allergy Appl Immunol (1988) 0.81
Adaptation of BTI-TN5B1-4 (high five) insect cells for large-scale production in a stirred bioreactor. Biotechniques (1999) 0.81
Effect of a lipopeptidic formulation on macrophage activation and peptide presentation to T cells. Vaccine (1994) 0.81
IgE-dependent platelet cytotoxicity against helminths. Adv Exp Med Biol (1985) 0.80
Properties of serine proteases of Schistosoma mansoni schistosomula involved in the regulation of IgE synthesis. Scand J Immunol (1988) 0.80
IgG response of rats and humans to the released products of schistosomula of Schistosoma mansoni. Parasitology (1985) 0.80
Immunological response of major histocompatibility complex class II-deficient (Abeta(o)) mice infected by the parasite Schistosoma mansoni. Scand J Immunol (1998) 0.80
[Hodgkin's disease and Epstein-Barr virus]. Ann Biol Clin (Paris) (2004) 0.80
Activation of rat and human eosinophils by soluble factor(s) released by Schistosoma mansoni Schistosomula. Cell Immunol (1982) 0.80
T-cell responsiveness towards various synthetic peptides of the P28 antigen in rat and mouse models during Schistosoma mansoni infection. Int Arch Allergy Appl Immunol (1990) 0.80
Regulatory role of a tripeptide (TKP) from the second constant domain of immunoglobulin G--I. Inhibition of rat and human macrophage activities. Int J Immunopharmacol (1985) 0.80
Direct evidence of cytoplasmic delivery of PKC-alpha, -epsilon and -zeta pseudosubstrate lipopeptides: study of their implication in the induction of apoptosis. FEBS Lett (1999) 0.80
Convergent peptide libraries, or mixotopes, to elicit or to identify specific immune responses. Curr Opin Immunol (1999) 0.80
Defined antigens secreted by the larvae of schistosomes protect against schistosomiasis: induction of cytotoxic antibodies in the rat and the monkey. Eur J Immunol (1985) 0.79
The mixotope: a combinatorial peptide library as a T cell and B cell immunogen. Eur J Immunol (1994) 0.79
Interleukin-6 is the main mediator of the interaction between monocytes and platelets in the killing of Schistosoma mansoni. Eur Cytokine Netw (1991) 0.79
HLA class II polymorphism influences onset and severity of pathology in Schistosoma mansoni-infected transgenic mice. Infect Immun (2001) 0.79
[Antigens of Toxoplasma gondii with a diagnostic and potential immunoprophylactic value: new strategies of identification]. Ann Biol Clin (Paris) (1989) 0.79
Macrophages as effector cells in helminth infections. Trans R Soc Trop Med Hyg (1983) 0.79
Determination of B-cell epitopes of nef HIV-I protein: immunogenicity related to their structure. Mol Immunol (1992) 0.79
Role of serine proteases of Schistosoma mansoni in the regulation of IgE synthesis. Scand J Immunol (1986) 0.78
Functional analysis of a T cell line specific for antiidiotypic antibodies to a Schistosoma mansoni protective epitope. II. Induction of protective immunity in experimental rat schistosomiasis. J Immunol (1991) 0.78
Novel hyperbranched glycomimetics recognized by the human mannose receptor: quinic or shikimic acid derivatives as mannose bioisosteres. Chembiochem (2001) 0.78
Homologous T and B cells immortalized in vitro by the Epstein-Barr virus exhibit differential genetical and functional features. Int J Oncol (1997) 0.78
Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells. Clin Exp Immunol (2002) 0.78
Role of interleukin-7 in the relation between Schistosoma mansoni and its definitive vertebrate host. Microbes Infect (1999) 0.78
Genes involved in obesity: Adipocytes, brain and microflora. Genes Nutr (2006) 0.78
Evaluation of the effect of Sm28GST-derived peptides in murine hepatosplenic schistosomiasis: interest of the lipopeptidic form of the C-terminal peptide. Mol Immunol (1994) 0.78
Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice. Arthritis Rheum (1999) 0.78